A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants
Linglei Jiang(Johns Hopkins University), Kenneth W. Witwer(Johns Hopkins University)
Cited by 25
Related Papers
Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications
|Journal of Extracellular Vesicles|2019|652
Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to <i>Macaca nemestrina</i>
|Journal of Extracellular Biology|2022|177
Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid
|Frontiers in Genetics|2013|148
Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers
|Journal of Alzheimer s Disease|2022|51